BioGentech Corp. Confirms Successful Termination of Its Unauthorized Listing on Berlin-Bremen Stock Exchange
26 mai 2004 09h00 HE
|
Cobalis Corp
IRVINE, Calif., May 26, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a publicly held Nevada corporation dedicated to developing and commercializing over-the-counter (OTC) products for the...
BioGentech Announces ClinDatrix as CRO for Phase III Trials
29 avr. 2004 16h30 HE
|
Cobalis Corp
IRVINE, Calif., April 29, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today that it has entered...
BioGentech's Trading Symbol Erroneously Receives "E"
07 avr. 2004 14h08 HE
|
Cobalis Corp
IRVINE, Calif., April 7, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, today announced that the letter "E" it...
BioGentech Awarded Australian Patent Covering the Use of Cyanocobalamin (Vitamin B12) for the Treatment of Seasonal Allergies
01 avr. 2004 18h52 HE
|
Cobalis Corp
IRVINE, Calif., April 1, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today that it has recently...
BioGentech Finalizes Outsourcing Partnerships for Prehistin Phase III Clinical Trials
31 mars 2004 16h54 HE
|
Cobalis Corp
IRVINE, Calif., March 31, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today the finalization of...
BioGentech Receives FDA Approval to Begin Phase III Clinical Trials
26 mars 2004 17h20 HE
|
Cobalis Corp
IRVINE, Calif., March 26, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today the Division of...
BioGentech Appoints Chairman and Additional Board Member
26 mars 2004 08h30 HE
|
Cobalis Corp
IRVINE, Calif., March 26, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergic medications, announced today that its Board of...